2018
DOI: 10.31661/jbpe.v8i2.930
|View full text |Cite
|
Sign up to set email alerts
|

An Aptamer-based Biosensor for Troponin I Detection in Diagnosis of Myocardial Infarction

Abstract: Background: Acute myocardial infarction (MI) accounts for one third of deaths. Cardiac troponin I (TnI) is a reliable biomarker of cardiac muscle tissue injury and is employed in the early diagnosis of MI. Objective:In this study, a molecular method is introduced to early diagnosis of MI by rapid detection of TnI. Materials and Methods: The detection method was based on electrochemical aptasensing, being developed using different methods and evaluation steps. A gold electrode was used as a transducer to succ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
21
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(21 citation statements)
references
References 35 publications
0
21
0
Order By: Relevance
“…Among them, acute myocardial infarction (AMI), acute coronary syndrome (ACS) and heart failure (HF) attract themost attention of scientists and clinicians [13]. Because of the very high frequency -one third of deaths [14,15] -of this pathology all over the world [2,7,8,12,[16][17][18][19][20][21], AMI is one of the WHO's major priorities [22]. Worldwide, between 5% and 20% of patients presenting to emergency departments (ED) do so with symptoms of myocardial infarction [23,24], which is defined as "cardiomyocyte necrosis in a clinical setting consistent with acute myocardial ischemia", according to the universal definition [25].…”
Section: Introductionmentioning
confidence: 99%
“…Among them, acute myocardial infarction (AMI), acute coronary syndrome (ACS) and heart failure (HF) attract themost attention of scientists and clinicians [13]. Because of the very high frequency -one third of deaths [14,15] -of this pathology all over the world [2,7,8,12,[16][17][18][19][20][21], AMI is one of the WHO's major priorities [22]. Worldwide, between 5% and 20% of patients presenting to emergency departments (ED) do so with symptoms of myocardial infarction [23,24], which is defined as "cardiomyocyte necrosis in a clinical setting consistent with acute myocardial ischemia", according to the universal definition [25].…”
Section: Introductionmentioning
confidence: 99%
“… 4 , 5 Various sensing methods, such as surface plasmon resonance, optical sensing, enzyme-linked immunosorbent assay, and electrochemistry, have been used to detect cTnI. 6 9 Detection probes include antibodies, aptamers, DNA, and RNA, which are used to quantify the level of cTnI. 10 12 Among these probes, aptamers have received great attention from researchers due to their selective binding affinity to their targets.…”
Section: Introductionmentioning
confidence: 99%
“…In particular, aptamers are more attractive as biosensors because of their unique features, such as their high performance to bind to targets. 9 In this research, an aptamer generated against cTnI was used as the detection probe to diagnose MI on the IDE surface.…”
Section: Introductionmentioning
confidence: 99%
“…Nanomaterials are developed due to exhibition of novel characteristics arising from their size-dependent features, and widely used in medical diagnoses and therapies [8][9][10]. These materials have a usage in biological and medical applications such as labeling of biomolecules [11], drug and gene delivery [12][13][14], rapid and sensitive microbial detections [15,16], antimicrobial materials [10,[17][18][19], detection and recognition of DNA and proteins [20][21][22], probing of intrinsic DNA structure [23], biologic substitutes and regenerative medicine [24], hyperthermia [25], separation of specific cell types [26] and MRI contrast agents [27]. Photothermal agents employed in PTT should absorb NIR light, while they possess photostability with no cytotoxicity.…”
Section: Introductionmentioning
confidence: 99%